Galectin Therapeutics Inc. (GALT) is a publicly traded Healthcare sector company. As of May 21, 2026, GALT trades at $2.21 with a market cap of $144.23M and a P/E ratio of -4.51. GALT moved +6.25% today. Year to date, GALT is -43.04%; over the trailing twelve months it is +71.32%. Its 52-week range spans $0.73 to $7.13. Analyst consensus is buy with an average price target of $11.00. Rallies surfaces GALT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading GALT stock inside the company?
Recent GALT insider activity includes ELDRED KARY bought 300, LEWIS JOEL sold 37.70K, CALLICUTT JACK W sold 20.35K, Jamil Khurram sold 21.45K, and LEWIS JOEL sold 27.73K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
GALT Key Metrics
Key financial metrics for GALT
Metric
Value
Price
$2.21
Market Cap
$144.23M
P/E Ratio
-4.51
EPS
$-0.48
Dividend Yield
0.00%
52-Week High
$7.13
52-Week Low
$0.73
Volume
0
Avg Volume
0
Revenue (TTM)
$0
Net Income
$-30.84M
Gross Margin
0.00%
Recent GALT Insider Trades
ELDRED KARY bought 300 (~$810) on Feb 6, 2026.
LEWIS JOEL sold 37.70K (~$134.85K) on Jan 6, 2026.
CALLICUTT JACK W sold 20.35K (~$74.70K) on Jan 6, 2026.
Jamil Khurram sold 21.45K (~$78.20K) on Jan 6, 2026.
LEWIS JOEL sold 27.73K (~$108.34K) on Jan 5, 2026.
Recent GALT insider activity includes ELDRED KARY bought 300, LEWIS JOEL sold 37.70K, CALLICUTT JACK W sold 20.35K, Jamil Khurram sold 21.45K, and LEWIS JOEL sold 27.73K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for GALT?
Yes. Rallies tracks GALT insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is GALT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for GALT. It does not provide personalized investment advice.
